Characteristics | 33° (N = 159) | 37° (N = 180) | P value |
---|---|---|---|
Age, years, median [IQR) | 67.1 [56.9–74.9] | 67.8 [59.5–77.1] | 0.23 |
Males, n (%) | 99 (62.2) | 111 (61.7) | 0.91 |
Charlson score, median [IQR) | 4 (2–6) | 4 (2–6) | 0.37 |
Comorbidities, n (%) | |||
Cardiovascular | 94/118 (79.7) | 116/139 (83.5) | 0.43 |
Pulmonary | 56/118 (47.4) | 66/139 (47.5) | 0.10 |
Cardiac arrest location, n (%) | 0.001 | ||
Home | 74/159 (46.5) | 95/180 (52.8) | |
Public place | 52/159 (32.7) | 29/180 (16.1) | |
Hospital | 33/159 (20.8) | 56/180 (31.1) | |
Arrest witnessed, n (%) | 154/159 (96.9) | 170/179 (95.0) | 0.39 |
Basic life support provided by bystander, n (%) | 120/153 (78.4) | 133/171 (77.8) | 0.89 |
First-recorded cardiac rhythm, n (%) | 0.97 | ||
Asystole | 125/143 (87.4) | 148/169 (87.6) | |
Pulseless electrical activity | 18/143 (12.6) | 21/169 (12.4) | |
Cause of cardiac arrest, n (%) | * | ||
Cardiac | 43/159 (27.0) | 50/180 (27.8) | |
Asphyxia | 81/159 (51.0) | 9/180 (50.5) | |
Anaphylaxis | 4/159 (2.5) | 3/180 (1.7) | |
Neurological | 5/159 (3.1) | 4/180 (2.2) | |
Other medical cause | 15/159 (9.4) | 16/180 (8.9) | |
Pulmonary embolism | 8/159 (5.0) | 9/180 (5.0) | |
Trauma | 1/159 (0.6) | 2/180 (1.1) | |
Drug poisoning | 0/159 (0.0) | 4/180 (2.2) | |
Drowning | 2/159 (1.3) | 1/180 (0.6) | |
GCS score, median [IQR] | 3 [3–3 | 3 [3–3] | 0.62 |
Time to randomisation, min, median [IQR] | 241.0 [192.0–285.0] | 226.0 [178.5–276.5] | 0.21 |
Temperature, °C, median [IQR] | 35.5 [34.3–36.3] | 35.4 [34.4–36.5] | 0.86 |
No-flow time, min, median [IQR] | 2 [0–5] | 0 [0–5] | 0.10 |
Low-flow time, min, median [IQR] | 19 [10–28] | 19.0 [10–28] | 0.82 |
Serum lactate at admission, mmol/L, median [IQR] | 6.1 [3.7–10.6] | 7.3 [4.0–10.7] | 0.40 |
Epinephrine injection, n (%) | 150/159 (94.3) | 174/180 (96.7) | 0.30 |
Total epinephrine dose, mg, median [IQR] | 3 (2, 5) | 4 (2, 5) | 0.44 |
PCI, n (%) | 13/159 (8.2) | 13/180 (7.2) | 0.74 |
CAHP score, median [IQR] | 190 [170–212] | 195 [177–222] | 0.073 |
Type of vasoactive drug at admission, n (%) | |||
Norepinephrine | 90/159 (56.6) | 93/180 (51.7) | 0.36 |
Epinephrine | 83/159 (52.2) | 100/180 (55.6) | 0.54 |
Dobutamine | 7/159 (4.4) | 11/180 (6.1) | 0.48 |
Dopamine | 0/159 (0) | 1/180 (0.6) | 1.00 |
Early onset pneumonia, n (%) | 35 (22.0) | 40 (22.2) | 0.96 |